Biotricity Analyst Ratings
Biotricity Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/15/2023 | 184.33% | HC Wainwright & Co. | → $2 | Reiterates | → Buy |
| 07/15/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 07/15/2022 | 184.33% | HC Wainwright & Co. | $6 → $2 | Maintains | Buy |
| 03/07/2022 | 610.83% | Lake Street | → $5 | Initiates Coverage On | → Buy |
| 11/23/2021 | 753% | HC Wainwright & Co. | → $6 | Initiates Coverage On | → Buy |
| 07/01/2021 | 895.17% | Northland Capital Markets | → $7 | Initiates Coverage On | → Outperform |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/15/2023 | 184.33% | HC 溫賴特 & 有限公司. | → 2 美元 | 重申 | → 購買 |
| 2022 年 7 月 15 日 | — | 美心集團 | 降級 | 購買 → 持有 | |
| 2022 年 7 月 15 日 | 184.33% | HC 溫賴特 & 有限公司. | 6 美元 → 2 美元 | 維護 | 購買 |
| 03/07/2022 | 610.83% | 湖邊街 | → 5 美元 | 啟動覆蓋範圍 | → 購買 |
| 11/23/2021 | 753% | HC 溫賴特 & 有限公司. | → 6 美元 | 啟動覆蓋範圍 | → 購買 |
| 2021 年 1 月 7 日 | 895.17% | 北國資本市場 | → 7 美元 | 啟動覆蓋範圍 | → 跑贏大市 |
What is the target price for Biotricity (BTCY)?
生物性 (BTCY) 的目標價格是多少？
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on February 15, 2023. The analyst firm set a price target for $2.00 expecting BTCY to rise to within 12 months (a possible 184.33% upside). 4 analyst firms have reported ratings in the last year.
韋萊特有限公司於 2023 年 2 月 15 日報導了生物性（納斯達克股票代碼：BTCY）的最新價格目標。該分析師公司設定了 2.00 美元的價格目標，預計 BTCY 將在 12 個月內上升（可能上漲了 184.33％）。4 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Biotricity (BTCY)?
生物性（BTCY）的最新分析師評級是什麼？
The latest analyst rating for Biotricity (NASDAQ: BTCY) was provided by HC Wainwright & Co., and Biotricity reiterated their buy rating.
生物性（納斯達克股票代碼：BTCY）的最新分析師評級由溫賴特公司提供，生物技術重申了他們的購買評級。
When is the next analyst rating going to be posted or updated for Biotricity (BTCY)?
生物性（BTCY）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biotricity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biotricity was filed on February 15, 2023 so you should expect the next rating to be made available sometime around February 15, 2024.
分析師在進行了廣泛的研究後抵達股票評級，其中包括通過公共財務報表，與 Biotricity 的高管和客戶交談以及收聽盈利會議電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。生物性的最後一個評級已於 2023 年 2 月 15 日提交，因此您應該期望下一個評分將在 2024 年 2 月 15 日左右的某個時間提供。
Is the Analyst Rating Biotricity (BTCY) correct?
分析師評級生物性 (BTCY) 是否正確？
While ratings are subjective and will change, the latest Biotricity (BTCY) rating was a reiterated with a price target of $0.00 to $2.00. The current price Biotricity (BTCY) is trading at is $0.70, which is within the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的生物性（BTCY）評級重申，目標價格為 0.00 美元至 2.00 美元。當前價格生物性（BTCY）的交易價格為 0.70 美元，該價格在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。